Follow
Deepa Sampath
Deepa Sampath
Associate Professor
No verified email
Title
Cited by
Cited by
Year
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia
M Fabbri, A Bottoni, M Shimizu, R Spizzo, MS Nicoloso, S Rossi, ...
Jama 305 (1), 59-67, 2011
3662011
microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival
S Rossi, M Shimizu, E Barbarotto, MS Nicoloso, F Dimitri, D Sampath, ...
Blood, The Journal of the American Society of Hematology 116 (6), 945-952, 2010
3022010
Nucleoside analogs: molecular mechanisms signaling cell death
B Ewald, D Sampath, W Plunkett
Oncogene 27 (50), 6522-6537, 2008
2832008
Mechanisms of apoptosis induction by nucleoside analogs
D Sampath, VA Rao, W Plunkett
Oncogene 22 (56), 9063-9074, 2003
2692003
Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia
D Sampath, C Liu, K Vasan, M Sulda, VK Puduvalli, WG Wierda, ...
Blood, The Journal of the American Society of Hematology 119 (5), 1162-1172, 2012
2462012
H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation
B Ewald, D Sampath, W Plunkett
Molecular cancer therapeutics 6 (4), 1239-1248, 2007
2242007
S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine
Z Shi, A Azuma, D Sampath, YX Li, P Huang, W Plunkett
Cancer research 61 (3), 1065-1072, 2001
1812001
Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial
D Sampath, J Cortes, Z Estrov, M Du, Z Shi, M Andreeff, V Gandhi, ...
Blood 107 (6), 2517-2524, 2006
1722006
Effects of nerve growth factor on glutathione peroxidase and catalase in PC 12 cells
D Sampath, GR Jackson, K Werrbach‐Perez, JR Perez‐Polo
Journal of neurochemistry 62 (6), 2476-2479, 1994
1561994
The BTK inhibitor ARQ 531 targets ibrutinib-resistant CLL and Richter transformation
SD Reiff, R Mantel, LL Smith, JT Greene, EM Muhowski, CA Fabian, ...
Cancer discovery 8 (10), 1300-1315, 2018
1422018
miRNAs and their potential for use against cancer and other diseases
E Tili, JJ Michaille, V Gandhi, W Plunkett, D Sampath, GA Calin
Future Medicine Ltd 3 (5), 521-537, 2007
1222007
BRD4 profiling identifies critical chronic lymphocytic leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor
HG Ozer, D El-Gamal, B Powell, ZA Hing, JS Blachly, B Harrington, ...
Cancer discovery 8 (4), 458-477, 2018
1162018
Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation
D Sampath, GA Calin, VK Puduvalli, G Gopisetty, C Taccioli, CG Liu, ...
Blood, The Journal of the American Society of Hematology 113 (16), 3744-3753, 2009
1062009
TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation
VK Puduvalli, D Sampath, JM Bruner, J Nangia, R Xu, AP Kyritsis
Apoptosis 10, 233-243, 2005
912005
Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation
G Gopisetty, J Xu, D Sampath, H Colman, VK Puduvalli
Oncogene 32 (26), 3119-3129, 2013
872013
XPO1 inhibition using selinexor synergizes with chemotherapy in acute myeloid leukemia by targeting DNA repair and restoring topoisomerase IIα to the nucleus
P Ranganathan, T Kashyap, X Yu, X Meng, TH Lai, B McNeil, ...
Clinical Cancer Research 22 (24), 6142-6152, 2016
832016
Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine
D Sampath, Z Shi, W Plunkett
Molecular pharmacology 62 (3), 680-688, 2002
822002
Efficacy of onalespib, a long-acting second-generation HSP90 inhibitor, as a single agent and in combination with temozolomide against malignant gliomas
A Canella, AM Welker, JY Yoo, J Xu, FS Abas, D Kesanakurti, ...
Clinical Cancer Research 23 (20), 6215-6226, 2017
692017
HDAC inhibition induces microRNA-182, which targets RAD51 and impairs HR repair to sensitize cells to sapacitabine in acute myelogenous leukemia
TH Lai, B Ewald, A Zecevic, C Liu, M Sulda, D Papaioannou, R Garzon, ...
Clinical cancer research 22 (14), 3537-3549, 2016
622016
Design of new anticancer therapies targeting cell cycle checkpoint pathways
D Sampath, W Plunkett
Current opinion in oncology 13 (6), 484-490, 2001
612001
The system can't perform the operation now. Try again later.
Articles 1–20